Suppr超能文献

先天性程序性死亡配体1(Innate PD-L1)限制T细胞介导的脂肪组织炎症,并改善饮食诱导的肥胖。

Innate PD-L1 limits T cell-mediated adipose tissue inflammation and ameliorates diet-induced obesity.

作者信息

Schwartz Christian, Schmidt Viviane, Deinzer Andrea, Hawerkamp Heike C, Hams Emily, Bayerlein Jasmin, Röger Ole, Bailer Moritz, Krautz Christian, El Gendy Amr, Elshafei Moustafa, Heneghan Helen M, Hogan Andrew E, O'Shea Donal, Fallon Padraic G

机构信息

Mikrobiologisches Institut - Klinische Mikrobiologie, Immunologie und Hygiene, Universitätsklinikum Erlangen and Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, D-91054 Erlangen, Germany.

Medical Immunology Campus Erlangen, FAU Erlangen-Nürnberg, D-91054 Erlangen, Germany.

出版信息

Sci Transl Med. 2022 Mar 9;14(635):eabj6879. doi: 10.1126/scitranslmed.abj6879.

Abstract

Obesity has become a major health problem in the industrialized world. Immune regulation plays an important role in adipose tissue homeostasis; however, the initial events that shift the balance from a noninflammatory homeostatic environment toward inflammation leading to obesity are poorly understood. Here, we report a role for the costimulatory molecule programmed death-ligand 1 (PD-L1) in the limitation of diet-induced obesity. Functional ablation of PD-L1 on dendritic cells (DCs) using conditional knockout mice increased weight gain and metabolic syndrome during diet-induced obesity, whereas PD-L1 expression on type 2 innate lymphoid cells (ILC2s), T cells, and macrophages was dispensable for obesity control. Using in vitro cocultures, DCs interacted with T cells and ILC2s via the PD-L1:PD-1 axis to inhibit T helper type 1 proliferation and promote type 2 polarization, respectively. A role for PD-L1 in adipose tissue regulation was also shown in humans, with a positive correlation between PD-L1 expression in visceral fat of people with obesity and elevated body weight. Thus, we define a mechanism of adipose tissue homeostasis controlled by the expression of PD-L1 by DCs, which may be a clinically relevant finding with regard to immune-related adverse events during immune checkpoint inhibitor therapy.

摘要

肥胖已成为工业化世界中的一个主要健康问题。免疫调节在脂肪组织稳态中起着重要作用;然而,导致肥胖的从非炎症性稳态环境向炎症状态转变的初始事件却知之甚少。在此,我们报道了共刺激分子程序性死亡配体1(PD-L1)在限制饮食诱导的肥胖中的作用。使用条件性敲除小鼠对树突状细胞(DCs)上的PD-L1进行功能缺失,会增加饮食诱导肥胖期间的体重增加和代谢综合征,而2型固有淋巴细胞(ILC2s)、T细胞和巨噬细胞上的PD-L1表达对于肥胖控制是可有可无的。通过体外共培养,DCs分别通过PD-L1:PD-1轴与T细胞和ILC2s相互作用,以抑制1型辅助性T细胞增殖并促进2型极化。在人类中也显示出PD-L1在脂肪组织调节中的作用,肥胖人群内脏脂肪中PD-L1表达与体重升高呈正相关。因此,我们确定了一种由DCs表达的PD-L1控制的脂肪组织稳态机制,这对于免疫检查点抑制剂治疗期间与免疫相关的不良事件可能是一个具有临床相关性的发现。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验